Table 2.

Patient characteristics by region and race (2000–2008).

Characteristics	Total (N=43,637)	White (N=39,647)			Black (N=3,990)
		US14 (N=33,813)	South (N=5,834)	p-value	US14 (N=2,369)	South (N=1,621)	p-value
Age at diagnosis (%)
Mean (SD)	63.3 (15.8)	63.6 (15.6)	63.3 (15.2)	0.15	60.2 (16.8)	59.5 (17.6)	0.22
Median (IQR)	64.0 (53,76)	64 (53, 76)	64 (54, 75)		61 (49, 73)	60 (49, 73)
≥ 65	21,034 (48.2)	16,521 (48.9)	2,847 (48.8)	0.93	1,006 (42.5)	660 (40.7)	0.27
< 65	22,603 (51.8)	17,292 (51.1)	2,987 (51.2)		1,363 (57.5)	961 (59.3)
Cancer stage (%)				0.0009			0.01
0	81 (0.2)	65 (0.2)	9 (0.2)		3 (0.1)	4 (0.3)
I	8,447 (19.6)	6,648 (19.9)	1,104 (19.2)		414 (17.9)	281 (17.7)
II	3,001 (7.0)	2,298 (6.9)	450 (7.8)		143 (6.2)	110 (6.9)
III	13,008 (30.2)	10,220 (30.6)	1,795 (31.2)		559 (24.2)	434 (27.4)
IV	11,036 (25.7)	8,283 (24.8)	1,493 (26.0)		745 (32.3)	515 (32.5)
Unstaged	7,445 (17.3)	5,856 (17.6)	902 (15.7)		446 (19.3)	241 (15.2)
Grouped Cancer stage (%)				0.002			0.004
Stage 0–II	11,529 (26.8)	9,011 (27.0)	1,563 (27.2)		560 (24.2)	395 (24.9)
Stage III–IV	24,044 (55.9)	18,503 (55.5)	3,288 (57.2)		1,304 (56.5)	949 (59.9)
Unstaged	7,445 (17.3)	5,856 (17.6)	902 (15.7)		446 (19.3)	241 (15.2)
Surgery				0.13			0.51
Yes	32,786 (75.7)	25,822 (77.0)	4,413 (76.1)		1,525 (64.8)	1,026 (63.8)
No	10,529 (24.3)	7,731 (23.0)	1,389 (23.9)		827 (35.2)	528 (36.2)
Insurance (%) ‡				<0.0001			0.02
Insured	8,703 (96.6)	6,654 (97.6)	1,229 (94.6)		500 (93.6)	320 (89.1)
Uninsured	306 (3.4)	163 (2.4)	70 (5.4)		34 (6.37)	39 (10.9)
5-year survival◊				0.0004			0.5
Yes	17,331 (39.7)	13,787 (40.8)	2,235 (38.3)		788 (33.3)	521 (32.1)
No	26,306 (60.3)	20,026 (59.2)	3,599 (61.7)		1,581 (66.7)	1,100 (67.9)

^‡Only available for cases diagnosed after 2007